Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1)

Citation

Shah, M, Bodoky, G, Starodub, A et al. 2021, 'Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1)', Asia Pacific Journal of Clinical Oncology.

Year

2021

ANU Authors

Fields of Research

  • Chemotherapy
  • Solid Tumours

Updated:  03 February 2023 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers